According to a real-world study, cenobamate was effective in patients with drug-resistant epilepsy (DRE), with 49.3% of patients achieved a 50% or greater reduction in seizure frequency at 3 months.

Epilepsy is one of the most common neurological disorders in the world. According to the World Health Organization, around 50 ...

In a 12-month observational study of young adults with tuberous sclerosis complex, add-on cenobamate improved executive ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Neuromodulation offers personalized, responsive ...

How can cannabidiol (CBD) be used to treat epilepsy? This is what a recent study published in Neuropsychopharmacology hopes to address as a team of researchers investigated the potential for using CBD ...

– New patient implants assigned to New Technology Ambulatory Payment Classification 1580 – End-of-service procedures elevated to Level 5 APC – Effective Jan. 1, 2026, will improve economics for ...

Extratemporal epileptogenic zones, male sex, and obesity are strongly associated with SUDEP risk among patients with drug-resistant epilepsy.

Emerging data show that many patients with drug-resistant epilepsy may be slipping through the cracks of standard clinical care, with an estimated 11% meeting criteria for drug-resistant epilepsy yet ...

At the University Teaching Hospital of Kigali (CHUK), doctors performed Rwanda's first-ever epilepsy surgery, an intervention that does more than treat seizures. It is a life-saving intervention for ...

There’s a lack of awareness related to certain diseases. This makes it easier for people to believe in the myths surrounding ...

– Effective Jan. 1, 2026, will improve economics for hospitals performing Medicare procedures and significantly reduces a known barrier to procedure penetration LivaNova PLC (Nasdaq: LIVN), a ...